Time (days) | −7 | 1 | 8 | 15 | 22 | 29 | 36 | 43 | 64 | 92 |
---|---|---|---|---|---|---|---|---|---|---|
LAI PBO | 0.5 (1.15) | 0.4 (1.08) | 0.4 (1.02) | 0.7 (1.31) | – | – | 0.6 (1.15) | 0.4 (0.95) | 0.3 (0.7) | 0.4 (1.04) |
LAI 25 mg | 0.4 (1.19) | 0.4 (1.09) | 0.3 (1) | – | – | – | – | – | – | 0.3 (1.05) |
LAI 50 mg | 0.6 (1.29) | 0.5 (1.18) | 0.4 (1.01) | 0.6 (1.23) | – | – | 0.4 (0.92) | 0.3 (0.83) | 0.4 (0.92) | 0.3 (0.98) |
LAI 100 mg | 0.5 (1.05) | 0.4 (0.99) | 0.4 (1.05) | 0.7 (1.31) | – | – | 0.4 (0.94) | 0.5 (1.09) | 0.4 (0.89) | 0.3 (0.9) |
LAI 150 mg | 0.6 (1.24) | 0.6 (1.2) | 0.4 (1.01) | – | – | – | – | – | – | 0.3 (1.11) |
Oral PBO | – | 0.5 (1.15) | 0.5 (1.12) | 0.5 (1.14) | 0.5 (1.28) | 0.4 (1.05) | 0.4 (1.04) | 0.5 (1.28) | – | – |
Oral 3 mg | – | 0.4 (1.07) | 0.4 (1.12) | 0.4 (1.26) | 0.3 (0.98) | 0.4 (1.14) | 0.3 (0.88) | 0.2 (0.74) | – | – |
Oral 6 mg | – | 0.6 (1.46) | 0.5 (1.27) | 0.5 (1.09) | 0.4 (1.11) | 0.4 (1.06) | 0.4 (1.03) | 0.3 (0.97) | – | – |
Oral 9 mg | – | 0.4 (1.1) | 0.5 (1.15) | 0.4 (1) | 0.4 (0.94) | 0.5 (1.07) | 0.5 (1.1) | 0.4 (1.09) | – | – |
Oral 12 mg | – | 0.6 (1.29) | 0.8 (1.55) | 0.6 (1.42) | 0.7 (1.4) | 0.6 (1.34) | 0.5 (1.24) | 0.5 (1.2) | – | – |
Oral 15 mg | – | 0.5 (1.06) | 0.6 (1.14) | 0.6 (1.24) | 0.6 (1.14) | 0.4 (1.06) | 0.6 (1.29) | 0.4 (1.06) | – | – |
Oral OLZ | – | 0.5 (1.14) | 0.5 (1.22) | 0.3 (0.95) | 0.3 (0.98) | 0.3 (1) | 0.2 (0.86) | 0.3 (0.72) | – | – |
Abbreviations: LAI, long-acting injectable; OLZ, olanzapine; PBO, placebo.